[Report: Published in the Diagnostic and Treatment Guidelines]

The research test A-Cube has been published in the “2025 Diagnostic and Treatment Guidelines for Interstitial Lung Disease Associated with Collagen Disease.”

Interstitial lung disease is a difficult-to-treat condition associated with collagen diseases (rheumatoid arthritis, SLE, Sjögren’s syndrome, myositis, scleroderma, etc.). This guideline was jointly compiled by the Japanese Respiratory Society and the Japanese Rheumatism Association, and “A-Cube® (Proteobridge)” is listed in Chapter 1, General Discussion, “E. Autoantibody Testing.”

We will continue to contribute to the promotion of research in this field to help diagnose collagen diseases.

“Guidelines for the diagnosis and treatment of interstitial lung disease associated with collagen diseases 2025”

https://www.jrs.or.jp/publication/jrs_guidelines/20250327154832.html